Results 71 to 80 of about 30,227 (301)
Advanced Science, Volume 12, Issue 14, April 10, 2025.An optimized protocol is developed to differentiate human iPSCs into pituitary organoids and the cellular composition, intercellular interactions, and spatial organization within pituitary organoids are characterized via scRNA‐seq and Stereo‐seq.
Shengjie Wang +8 more
wiley +1 more source
Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro [PDF]
, 2001 Angiogenesis, the formation of a new blood supply, is an essential step in tumorigenesis. Although vascular endothelial growth factor (VEGF) is known to be a very potent angiogenic factor in most solid tumors, little is known about its production and ...
Gloddek, Jutta +7 more
core +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 4, Page 697-706, April 2025.Recurrent pregnancy loss (RPL) is a heterogeneous multifactorial syndrome. A customized management can lead to a good pregnancy outcome in more than a half of cases. Age <40 and AMH >1 ng/mL are the major positive predictors of live birth rate in RPL women.
Chiara Tersigni +11 more
wiley +1 more source
Current Therapeutic Research, 2021 : Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like ...
Mohammed Fouad Shalaby, MD +5 more
doaj
Bromocriptine, a Dopamine (D2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia [PDF]
Journal of Clinical and Diagnostic Research, 2013 Introduction: Bromocriptine, an ergot derivative, is an agonist at the dopamine 2 receptor and a sympatholytic. It is a well established drug in Parkinsonism, hyperprolactinaemia and acromegaly and it has various other clinical indications like ...
Harish Kumar V.S. +5 more
doaj +1 more source
Endocrine, 2014 Metformin was found to affect plasma levels of some pituitary hormones. This study was aimed at investigating whether metformin treatment has an impact on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired ...
R. Krysiak, J. Okrzesik, B. Okopień
semanticscholar +1 more source
Journal of Prosthodontics, Volume 34, Issue S1, Page 46-61, April 2025.Abstract Sleep‐related bruxism (SRB) is a motor oral behavior characterized by tooth grinding and jaw clenching activity, reported by 8%–12% of the adult general population and 3% of older individuals. The frequency of one of its biomarkers, rhythmic masticatory muscle activity (RMMA), remains elevated across ages.
Cibele Dal Fabbro +4 more
wiley +1 more source
Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney [PDF]
, 2004 Dopamine D2-like receptor agonist bromocriptine protects against ischemia/reperfusion injury in rat kidney.BackgroundDopamine, via activation of D1-like and D2-like receptors, plays an important role in the regulation of renal sodium excretion. Recently,
Cambon, Claudie +5 more
core +1 more source
A review of neuroleptic malignant syndrome : incidence and features in Malta [PDF]
, 1995 This paper describes Malta’s first sample of Neuroleptic Malignant Syndrome (NMS) and reviews the current literature. A retrospective sample of all diagnosed cases of NMS was reviewed using Pope’s (1986) criteria. Twelve cases were identified yielding an
Grech, Anton, Saliba, Joseph R.
core
Bromocriptine and insulin secretion
Bioscience Reports, 1982 The dopaminergic drug bromocriptine inhibited the release of insulin from isolated mouse pancreatic islets. The effect was counteracted by haloperidol or pimozide. It is suggested that insulin release may be inhibited through activation of D-2 dopaminergic receptors in the pancreatic beta-cells.
Eva Gagerman +4 more
openaire +3 more sources